Tumour fatty acid metabolism in the context of therapy resistance and obesity
Fatty acid metabolism is known to support tumorigenesis and disease progression as well
as treatment resistance through enhanced lipid synthesis, storage and catabolism. More …
as treatment resistance through enhanced lipid synthesis, storage and catabolism. More …
[HTML][HTML] Lipid metabolism and cancer
Dysregulation in lipid metabolism is among the most prominent metabolic alterations in
cancer. Cancer cells harness lipid metabolism to obtain energy, components for biological …
cancer. Cancer cells harness lipid metabolism to obtain energy, components for biological …
Emerging functions of the EGFR in cancer
S Sigismund, D Avanzato, L Lanzetti - Molecular oncology, 2018 - Wiley Online Library
The physiological function of the epidermal growth factor receptor (EGFR) is to regulate
epithelial tissue development and homeostasis. In pathological settings, mostly in lung and …
epithelial tissue development and homeostasis. In pathological settings, mostly in lung and …
Lipids in the tumor microenvironment: From cancer progression to treatment
Over the past decade, the study of metabolic abnormalities in cancer cells has risen
dramatically. Cancer cells can thrive in challenging environments, be it the hypoxic and …
dramatically. Cancer cells can thrive in challenging environments, be it the hypoxic and …
Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer
Z Tracz-Gaszewska, P Dobrzyn - Cancers, 2019 - mdpi.com
A distinctive feature of cancer cells of various origins involves alterations of the composition
of lipids, with significant enrichment in monounsaturated fatty acids. These molecules, in …
of lipids, with significant enrichment in monounsaturated fatty acids. These molecules, in …
[HTML][HTML] Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer
C Wang, M Shi, J Ji, Q Cai, Q Zhao, J Jiang… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Cancer cells are characterized by metabolic alterations. Thereinto, Stearoyl-CoA
Desaturase 1 (SCD1), an enzymatic node located in the conversion of saturated fatty acids …
Desaturase 1 (SCD1), an enzymatic node located in the conversion of saturated fatty acids …
Novel insights on lipid metabolism alterations in drug resistance in cancer
R Yang, M Yi, B Xiang - Frontiers in cell and developmental biology, 2022 - frontiersin.org
Chemotherapy is one of the primary treatments for most human cancers. Despite great
progress in cancer therapeutics, chemotherapy continues to be important for improving the …
progress in cancer therapeutics, chemotherapy continues to be important for improving the …
EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells
S Talukdar, L Emdad, SK Das, PB Fisher - Advances in cancer research, 2020 - Elsevier
Abstract The Epidermal Growth Factor Receptor (EGFR) is frequently expressed at elevated
levels in different forms of cancer and expression often correlates positively with cancer …
levels in different forms of cancer and expression often correlates positively with cancer …
Reprogramming of lipid metabolism in lung cancer: An overview with focus on EGFR-Mutated non-small cell lung cancer
K Eltayeb, S La Monica, M Tiseo, R Alfieri, C Fumarola - Cells, 2022 - mdpi.com
Lung cancer is the leading cause of cancer deaths worldwide. Most of lung cancer cases are
classified as non-small cell lung cancers (NSCLC). EGFR has become an important …
classified as non-small cell lung cancers (NSCLC). EGFR has become an important …
Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches
The constant changes in cancer cell bioenergetics are widely known as metabolic
reprogramming. Reprogramming is a process mediated by multiple factors, including …
reprogramming. Reprogramming is a process mediated by multiple factors, including …